We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Contact Lens with Noninvasive Glucose Sensor

By HospiMedica staff writers
Posted on 21 Apr 2003
Scientists have created a thin plastic sensor that changes color based on the concentrations of glucose in the body and can be incorporated into a contact lens. More...
The development was reported in the April 11, 2003, online issue of Analytical Chemistry.

When embedded into contact lenses, the sensor will allow diabetic patients to determine their glucose levels by looking into a special mirror to compare the color of the sensing material with a chart on the mirror indicating glucose concentrations. The sensor will change from red, indicating dangerously low concentrations of glucose, to violet, indicating dangerously high levels. When the glucose level is normal, the sensor will be green. The researchers are still determining the number of detectable gradations but expect it to be as high as those provided by finger-stick meters.

"There has been increasing demand for continuous, noninvasive glucose monitoring due to the increasing number of people diagnosed with diabetes and the recognition that the long-term outcome of these patients can be dramatically improved by careful glucose monitoring and control,” said Sanford A. Asher, Ph.D., professor of chemistry at the University of Pittsburgh (PA, USA).

The new sensor was created by Dr. Asher and David Finegold, M.D., professor of pediatrics at the university's School of Medicine. The patented technology is owned by the University of Pittsburgh, which has licensed it to a new startup company that will commercialize the technology. The researchers expect that the technology will be able to be incorporated into currently available commercial contact lenses, which would be replaced weekly.




Related Links:
Univ. of Pittsburgh

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.